KELLY WRIGHT: Open Payments
NPI 1720479223 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,752 in 118 payments from 21 companies in 2025. Trend: 2023 $1,007 · 2024 $2,116 · 2025 $1,752
Food & beverage: $1,752
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $602 |
| Janssen Biotech, Inc. | 14 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $144 |
| Aimmune Therapeutics, Inc. | 7 | $126 |
| Phathom Pharmaceuticals, Inc. | 17 | $121 |
| Gilead Sciences, Inc. | 4 | $77 |
| Smith+Nephew, Inc. | 4 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| QOL Medical, LLC | 2 | $46 |
| PFIZER INC. | 2 | $35 |
Products named: RINVOQ, TREMFYA, ZENPEP, VOQUEZNA, CREON, SKYRIZI, EOHILIA, ENTYVIO.
Industry payments across AR — which companies pay providers there.
